With the aim of helping people in affected areas regain vitality and recover as quickly as possible, Takeda is setting aside some of the revenue generated by sales of the Alinamin to donate roughly ¥800 million every year for three years. The ﬁnancial assistance program for ﬁscal 2011 is shown in the table below. The Takeda Life and Livelihood Reconstruction Program supplies ﬁnancial assistance via the Japan NPO Center to NPOs providing basic humanitarian relief and infrastructure creation support services mainly to residents of the prefectures of Iwate, Miyagi, and Fukushima. An ofﬁce has been set up within the Japan NPO Center to coordinate its own activities in the region in partnership with various relevant organizations, and to support groups providing support in the area.
|Theme||Program Name||Recipient||Donation amount||Timeframe|
|Supporting various needs of affected people (NPOs)||
|Japan NPO Center||¥800 million||5 years|
|Revitalization of industry and human resource training (economic sphere)||
|Keizai Doyukai (Japan Association of Corporate Executives)||¥750 million||5 years|
|Think tank and advisory activities (think tanks)||
|Rebuild Japan Initiative Foundation||¥300 million||5 years|
|Creating opportunities for the next generation (public-private sector partnership)||
|U.S.-Japan Council||¥90 million||3 years|
|Youth leadership development (international society)||
|Global Fund for Education Assistance||¥60 million||3 years|
|Others||Central Community Chest of Japan||¥20 million||--|
|Tohoku New Business Council||¥20 million||--|
|Takeda Capacity Building Initiative||Japan Earthquake Local NPO Support Fund||¥20 million||--|
As of July 31, 2012
April 27, 2011, Osaka, Japan - Takeda Pharmaceutical Company Limited ("Takeda") today announced its decision to donate a part of the revenue derived from Alinamin® products (1) for the relief and recovery efforts for affected areas by The 2011 off the Pacific coast of Tohoku Earthquake.
Launched more than half a century ago, the Alinamin products of Takeda have been contributing to the health of Japanese people to relief everyday fatigue. Based on the determined wishes for recovery of the affected areas and people there, with the slogan of "Support for Japan's Genki (2) and Recovery", Takeda will donate approximately 800 million Japanese yen a year, for a multiple number of years, that is equivalent to annual consumption of the number of tablets and bottles of Alinamin (3) with the expectation that those who take Alinamin will join the Company in those wishes.
To date, Takeda has made a cash donation to The Japanese Red Cross Society, donations of both ethical and over-the-counter pharmaceutical products as an urgent and immediate support, and also conducted the matching gift program, in cooperation with Takeda Worker's Union, for the relief support of the affected areas and people.
Takeda will conduct "Support for Japan's Genki and Recovery" by Alinamin with the strong this belief that it is indispensable for the company to continuously make supports for the recovery of the areas enormously affected by the Earthquake. As a company engaged in the business directly related to the people's health, Takeda will continue all other supports that are feasible for the Company.
April 20, 2011, Osaka, Japan - Takeda Pharmaceutical Company Limited ("Takeda") today announced that the amount under the matching gift program, jointly conducted by the Company and the Takeda Worker's Union, totaled 76,292 thousand Japanese Yen including the Company's contribution of the same amount donated from its employees. This amount will be donated to an NPO "Japan Platform", that is an international emergency humanitarian aid organization.
Takeda has made a cash donation to The Japanese Red Cross Society and also to the Japan NPO Center that is supporting a variety of NPOs and NGOs conducting relief efforts now. Also, Takeda is donating both ethical and over-the-counter pharmaceutical products(*) under the initiatives of the Ministry of Health, Labour and Welfare, the Japanese Pharmaceutical Manufacturers Association, and Japan Self-Medication Industry.
Takeda will continue all other supports that are feasible for the Company, while offering the scheme that will facilitate and encourage Takeda's employees to engage in volunteer activities.
(*) Ethical pharmaceutical products: Treatments for diabetes mellitus, hypertension, peptic ulcers, etc.
Over-the-counter pharmaceutical products: Alinamin®, Benza® Block, Benza® Ace, etc.
March 14, 2011, Osaka, Japan --- Takeda Pharmaceutical Company Limited ("Takeda") today announced 300 million Japanese yen donation to aid emergency relief for the earthquake on March 11, through The Japanese Red Cross Society, in view of the huge damages in the wide geographical area affected in prefectures such as Iwate, Miyagi, Fukushima and others.
In addition to the cash donation aforementioned, Takeda is planning the donation of pharmaceutical products (both ethical and over-the-counter) and all other supports that are feasible for the Company.
We would like to express heartfelt condolences to the families of the victims, and we also sincerely wish the safety of the people affected by this earthquake and the earliest possible recovery of the relevant region.